In gefitinib-resistant non-small cell lung cancer cells, SNX1 was found to inhibit the endocytosis and degradation of MET whose overexpression was believed to be responsible for gefitinib resistance in non-small cell lung cancer19. This evidence concerns the gene SNX1 and non-small cell lung carcinoma.